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An enzyme-linked immunosorbent assay (ELISA) for analysis of 
fluoroquinolones residues in animal feeds has been developed and validated according 
to Commission Decision 2002/657/EC criteria. Initially, direct and indirect competitive 
ELISA formats were compared for one fluoroquinolone polyclonal antibody (As172) 
and two monoclonal antibodies (FQ8 and FQ10), in order to find the best combination 
in terms of simplicity, reduction of matrix effect and sensitivity. The optimal 
methodology was identified as direct ELISA format using polyclonal antibody As172, 
able to avoid the matrix effect by only 10-fold dilut on of feed samples. Following the 
optimized ELISA protocol, the half-maximal inhibitory concentration (IC50) and limit of 
detection (LOD) for enrofloxacin was determined to be 15.2 ng.g-1 and 1.3 ng.g-1, 
respectively. Decision limit (CCα) obtained was 10 ng.g
-1 and detection capability (CCβ) 
was 20 ng.g-1. Significant cross-reactivity values (> 42 %) were obtained for eight 
fluoroquinolones by the optimized ELISA method. More ver, comparison of results 
from ELISA to that of liquid chromatography with fluorescence detection (LC-Fl) 
showed good correlation. In general, the developed ELISA allows a rapid, sensitive, and 
low-cost screening analysis of fluoroquinolone residues in animal feeds. 
 
















Quinolones are synthetic antimicrobials widely used in human and veterinary 
medicine (Greene & Budsberg, 1993; Suh & Lorber, 1995). Quinolones have a general 
structure consisting of a 1-substituted-1, 4-dihydro-4-oxopyridine-3-carboxylic moiety 
combined with an aromatic or heteroaromatic ring. Fluoroquinolones are derived from 
nalidixic acid by adding 6-fluoro and 7-piperazinyl groups, which enhances their 
antibacterial action and makes them more effective against gram-negative bacteria and 
some gram-positive bacteria compared to previously developed quinolones (Hernández-
Arteseros, Barbosa, Compañó, & Prat, 2002). 
In the European Union (EU), in veterinary practices, fluoroquinolones can only be 
introduced in feedstuffs for therapeutic or prophylactic purposes, under veterinary 
prescription (Kools, Moltmann, & Knacker, 2008). However, the use of antimicrobials, 
other than coccidiostats and histomonostats, as growth promoters is banned in EU 
("Regulation (EC) No 1831/2003 on Additives for Use in Animal Nutrition," 2003).  
On the other hand, fluoroquinolones can also get uninte tionally in feeds, as a 
result of cross contamination, a phenomenon where by feeds are contaminated during 
production, usually in the low mg.kg-1 range or below. The unknown exposure of non-
target animal species to contaminated feeds may lead to the occurrence of traces of 
residues of antimicrobials in foods of animal origin, which may have a potential risk to 
humans like spreading of antimicrobial resistance (Wassenaar, 2005) or allergies in 
hypersensitive individuals. In this context, reliabe analytical methods for the effective 















LC based methods are well suited for confirmatory analysis, especially with mass 
spectrometry detection (Bogialli, D’Ascenzo, Di Corcia, Laganà, & Nicolardi, 2008; 
Jiménez, Rubies, Centrich, Companyó, & Guiteras, 2011; Zafra-Gómez, Garballo, 
Ballesteros, Navalón, & García-Ayuso, 2008), but are expensive, time consuming, and 
often require complicated sample preparation. Thus, laboratories which manage a large 
amount of samples need simple and sensitive screening methods with a broad range of 
detectability to detect non-compliant samples and thus to decrease the number of 
samples requiring further confirmatory analysis. In addition feed mills also need simple 
and reliable methods to control the production batches. In this sense, the approach based 
on enzyme-linked immunosorbent assays (ELISA) appears highly convenient  
Few screening methodologies based on ELISAs have ben reported for 
fluoroquinolones in food matrices (Huet, et al., 2006; Jinqing, Haitang, & Ziliang, 2011; 
Sheng, Li, Xu, Yuan, & Wang, 2011; Tittlemier, et al., 2008; Wang, et al., 2007). Dual-
colorimetric ELISA developed for full-fat milk samples based on immunoreagents 
specifically allowed a sensitive determination of fluoroquinolones with a detection limit 
of 2.4 ng.mL-1 (Jiang, et al., 2013). However, ELISA assays for the determination of 
fluroquinolones in animal feeds are limited; commercial ELISA kits for determination 
of fluoroquinolones in feed samples have been tested (Scortichini, Annunziata, Di 
Girolamo, Buratti, & Galarini, 2009a). Most of the commercially available kits are 
based on indirect ELISA format developed for specific analytes, and only few allow the 
detection of a broad range of compounds, and samples considered having complex 
matrices. Moreover, sample treatment steps are tedious in some cases, so simple and 















The main objective of this work was to develop a rapid, simple and sensitive 
ELISA method for the analysis of 10 fluoroquinolones in feed samples. The new 
methodology is based on immunoreagents specifically developed to detect a wide range 
of congeners of fluoroquinolones. Two monoclonal antibodies and one polyclonal 
antiserum were tested in both direct and indirect ELISA formats to identify the most 
suitable approach. Optimization of the ELISA method was performed in terms of 
simplicity, reduction of matrix effect and sensitivity.   
2. Materials and methods 
2.1. Chemicals and immunoreagents 
Norfloxacin, sarafloxacin, danofloxacin, oxolinic acid, flumequine, difloxacin, 
enrofloxacin, ofloxacin and marbofloxacin were purchased from Fluka (Buchs, 
Switzerland). Ciprofloxacin was kindly provided by UQUIFA S.A (Lliça de Vall, 
Spain). Sulfadiazine, amoxicillin, Penicillin G potassium salt, neomycin sulfate, 
tetracycline-hydrogen chloride, doxycycline, chloramphenicol, tylosin and robenidine 
were acquired from Aldrich Chemical Co. (Milwaukee, WI). Sulfuric acid (H2SO4, 
98%) and hydrochloric acid (HCl, 37%) were obtained from Merck (Darmstadt, 
Germany). Dimethyl sulfoxide, hydrogen peroxide (30%) and 3, 3’, 5, 5’-
tetramethylbenzidine (TMB) were purchased from Fluka (Buchs, Switzerland). 
Acetonitrile (ACN, HPLC gradient grade) was obtained from Panreac Quimica 
(Barcelona, Spain). Anti-Rabbit IgG (whole molecule) and peroxidase antibody 
produced in goat were provided by Sigma Chemical Co. (St. Louis, MO). Horseradish 
peroxidase (type IV-A, activity of about 100 units per mg of solid) used for the 
production of enzyme tracer was purchased from Sigma-Aldrich. Ultrapure water 















preparation of the fluoroquinolone haptenized protein conjugates (PrEDA-BSA), 
monoclonal antibodies (FQ8, FQ10), antiserum (As172) and enzyme tracer (HRP-CC-
EDA) is described elsewhere (M. P. Marco, F. Sanchez-Baeza, & Pinacho, Haptenos e 
inmunoreactivos y su uso en la obtención de anticuerpos de familia e inmunoensayos 
para quinolonas, 2010; Pinacho, Sánchez-Baeza, & Marco, 2012). All immunoreagents 
were stored at -20 oC. Working aliquots were kept at 4oC and aliquots of enzyme tracer 
solutions were defrozen 1 week before use. 
The coating buffer (pH 9.6) was composed of 0.015 M of Na2CO3 and 0.035 M 
of NaHCO3 in Milli-Q water. The phosphate-buffered saline soluti n (PBS) with pH 7.5 
was 0.02 M KH2PO4 and 0.08 M Na2HPO4 in 0.8% saline solution (0.137 M NaCl and 
2.7 M KCl). PBST was PBS with 0.05% Tween 20. A soluti n of PBST-Ca (pH 7.5) 
was 0.01 M phosphate buffer and 2 mM of CaCl2 in a 1.6% saline solution containing 
0.1% Tween 20. The citrate buffer was 0.04 M solutin of sodium citrate adjusted to pH 
5.5 with HCl. The substrate solution contained 0.01% TMB and 0.004% H2O2 in citrate 
buffer. Buffer solutions were prepared every week and stored at 4 oC.  
2.2.  Instrumentation and apparatus 
The pH and conductivity of buffers and solutions were measured with 540 GLP 
pH meter and LF 340 conductimeter (WTW, Weilheim, Germany), respectively. 
Polystyrene microtiter plates were obtained from Nunc (Maxisorp, Roskilde, Denmark). 
A Heidolph Titramax 1000 vibrating platform shaker (Brinkmann Instruments, 
Westbury, NY, USA) was used to shake the microplates. Washing step was carried out 
using an automatic 96-well plate washer (ELx405, BioTek, Winooski, VT). 
SpectramaxPlus (Molecular Devices, Sunnyvale, CA, USA) was used to measure 















(Molecular Devices) and the analysis of competitive curves with a four parameter 
logistic equation was done by GraphPad Prism version 4 (GraphPad Software, San 
Diego, CA, USA). Unless otherwise indicated, data presented correspond to an average 
of at least two replicates. 
         HPLC analysis was performed with a Shimadzu LC system consisting of LC-
10ADVP pumps, a DGU-14A degasser, and FCV-10AL quatern ry valve (Shimadzu, 
China), SIL 10ADVP auto sampler (Shimadzu, USA) and RF-10AXL fluorescence 
detector (Shimadzu, Japan). The system was controlled via a CBM-20A controller 
(Shimadzu, USA). A Kinetex C18 (Phenomenex, 150 × 4.6 mm, 2.6 µm) column 
equipped with the corresponding guard cartridge (4 × 2 mm) was employed. 
2.3. Animal Feeds 
Feed samples (pig, cow, piglet, hen, chicken) were provided by the Catalan 
Association of Feed Manufacturers (ASFAC) and Labortori Agroalimentari de la 
Generalitat de Catalunya (LAGC). Feed samples were contained in polyvinylchloride 
(PVC) flasks and stored at 4 ºC. Samples in the form f pellets were ground to a fine 
powder with a domestic mill. Blank feed samples were analysed by LC-MS/MS (Chico, 
et al., 2008) and found free of fluroquinolones.  
For recovery studies, some feed samples were spiked at three different levels (5, 
50, 500 µg.g-1) with enrofloxacin following a procedure described elsewhere (Jiménez, 
Companyó, & Guiteras, 2009).  
2.4.  Extraction of feeds 
Extraction was performed by adding 5 mL of 0.05 M HCl and 5 mL of ACN to 50 















by Borràs et al (Borràs, Ríos-Kristjánsson, Companyó, & Prat, 2012). Briefly, the 
aqueous solution was added first to moisten the dry feed samples and improve 
extraction efficiency. The mixture was then shaken manually for 2 min, and then 1.1 
mL of 0.1 M PBS was added to the extraction mixture and centrifuged at 3500 g for 10 
min. The extracts were 10-fold diluted before ELISA analysis. 
For LC analysis, the same extraction procedure was applied, but no addition of 
PBS to the extraction mixture was performed.  
2.5.  Selection of immunoreagents concentrations  
Two dimensional checkerboard titration experiments were performed to select the 
optimal concentrations of immunoreagents to be employed in both direct and indirect 
ELISA formats. For the direct format, measurements were obtained from the binding of 
enzyme tracer at several concentrations (2 ng.mL-1 to 2 µg.mL-1, 100 µL/well) to a plate 
coated with antiserum As172 at different dilutions (1/1000 to 1/64000 and zero, 100 
µL/well) or with monoclonal antibodies FQ8 and FQ10 at several concentrations (2 
ng.mL-1 to 2 µg.mL-1 and zero, 100 µL/well). In the indirect format, the test was 
performed by measuring the binding of serial dilutions (1/1000 to 1/64000 and zero, 
100 µL/well) of antiserum As172 or monoclonal antibodies FQ8 and FQ10 at several 
concentrations (2 µg.mL-1 to 2 ng.mL-1 and zero, 100 µL/well) to wells coated with 
different concentrations of conjugates (2 µg.mL-1 to 2 ng.mL-1 and zero, 100 µL/well). 
The optimal concentrations of immunoreagents were chosen by considering a 
compromise between the enhancement of sensitivity and the reduction of the signal 
when diluting the immunoreagents. Concentrations of coating antigens and antiserum 
As172 or FQ8 and FQ10 monoclonal antibodies that produce 0.7-1 units of absorbance 















2.6. Optimal direct competitive ELISA 
The coating step was carried out by adding (100 µL/well) solution of As172 
(20,000 fold diluted in coating buffer) to the microplates. The plates were covered with 
adhesive sealers and incubated at room temperature for 3.5 hours. After that, the plates 
were washed 4 times with 10 mM PBST solution (300 µL/well). The competition step 
was performed by adding 50 µL standard solutions of flu roquinolones (from 10, 000 to 
0.01 nM in PBS) or feed extracts (diluted 10 fold in PBS) and 50 µL of enzyme tracer 
solution (1 µg.mL-1 in PBST-Ca) in to each well. The microplates were further 
incubated for 30 min at room temperature with agitation. After washing the plates 
following the previous procedure, 100 µL of the substrate solution was added into each 
well. Finally, the color development was stopped after 30 min at room temperature, 
with 2 M H2SO4 (50 µL/well). The absorbances were read at 450 nm. The standard 
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Where A is the maximal absorbance, B is the minimum absorbance, C is the 
concentration producing 50 % of the maximal absorbance (IC50), and D is the slope at 
the inflection point of the sigmoid curve. 
2.7.  Matrix Effect Studies.  
Standard curves obtained in feed extracts were compared with standard curves 
prepared in PBS to assess the matrix effect. Feed extracts were diluted at different levels 
















2.8.  LC analysis 
The LC-FL method used was developed and validated pr viously (Borràs, et al., 
2012). The mobile phase was composed of 0.01M oxalic acid (pH 4) and ACN. The 
flow rate was set to 1.2 mL.min-1. The elution profile starts with isocratic elution with 
12 % ACN for 8 min followed by a gradient elution from 12% to 30% of ACN in 4 min, 
set back to 12 % ACN in 2 min and finally 2 min for equilibration. The fluorimetric 
detector was set at excitation/emission wavelengths of 280/450 nm. The injection 
volume was 30 µL. Feed extracts were diluted 5 foldin mobile phase, filtered through 
0.45 µm nylon membrane and injected into the chromatographic system. 
2.9.  Validation Studies 
The immunoassay method was validated according to the Commission Decision 
2002/657/EC criteria ("Commission Decision (EC) No. 657/2002 Concerning the 
Performance of Analytical Methods and the Interpretation of Results," 2002). 
Parameters like precision, accuracy, limit of detection (LOD), decision limit (CCα), 
detection capability (CCβ), specificity, selectivity and ruggedness was determined.  
Blank feed extracts were spiked with enrofloxacin at six different concentrations 
(10, 22, 45, 90, 135, 180 µg.L-1) to assess the precision and trueness of the method. 
Moreover, blank feed samples were spiked at three diff rent concentrations (5, 50 and 
500 µg.g-1) with enrofloxacin to evaluate the recovery of them thod.  
For the assessment of specificity of the assay, compounds structurally related to 
enrofloxacin as well as other antimicrobials were tested to evaluate the cross reactivity 
in feed samples. Stock solutions (10 mM) were prepared in sodium hydroxide 50 mM 















prepared for each compound in PBS and measured with the ELISA. The 
fluoroquinolones tested were ciprofloxacin, marbofloxacin, danofloxacin, difloxacin, 
norfloxacin, ofloxacin, sarafloxacin, flumequine and oxolinic acid. The fluoroquinolone 
group specificity was evaluated by determining the cross reactivity of antibiotics from 
other classes (sulfonamides, macrolides, tetracyclines, coccidiostats, aminoglycosides, 
β-lactams and chloramphenicol). The cross reactivity (CR) values were calculated 
according to the equation: 
50
50
IC   
 x 100








The limit of detection (LOD) was calculated as the concentration resulting in 90 % of 
the maximum signal. 
For the determination of CCα and CCβ 20 blank samples were analysed in 
repetitive experiments. The two parameters were calculated using a method based on 
the variability in blank signals (Galarini, Buratti, Fioroni, Contiero, & Lega, 2011; 
Jiménez, Adrian, Guiteras, Marco, & Companyó, 2010).  
Minor variations in optimal values of some parameters thought to affect the 
immunoassay were introduced to evaluate the robustnes  of the method. Seven variables 
were selected and experiments were planned based on the Youden factorial design 
(Scortichini, et al., 2009a; Vander Heyden, Nijhuis, Smeyers-Verbeke, Vandeginste, & 
Massart, 2001; Youden & Steiner, 1975). The effect of each variable was estimated by 
subtracting the mean result obtained with the variable at higher level from the mean 
result obtained at lower level. The influence of each factor was evaluated by using a two 
















The absence of matrix effect after proper dilution f extracts, and hence the 
applicability to different feeds, was shown by applying the optimized ELISA method to 
chicken, hen, cow, and piglet feeds. Besides, blank feed samples spiked at three 
different concentrations (5, 50, 500 µg.g-1) with enrofloxacin were analysed with the 
ELISA method and a confirmatory LC-FL method. The correlation between the results 
from ELISA and LC-FL was used to demonstrate the reliability of the ELISA method as 
a screening and semi-quantitative analytical tool. 
3. Results and discussions 
3.1. Immunoassay evaluation and selection of ELISA 
The selection of the immunoreagents and final format w s performed based on 
sensitivity, reduction of matrix effect and selectivity of the assays. Enrofloxacin is the 
most widely applied fluroquinolone in veterinary and hence this compound was selected 
as a representative of other fluoroquinoles in preliminary studies. Polyclonal antiserum 
As172 and monoclonal antibodies FQ8 and FQ10 were employed in both direct and 
indirect ELISA formats, to select the conditions for the fluoroquinolones. A 
representative pig feed was used to run competitive ELISA for the assessment assay. 
First, proper concentrations of immunoreagents were chosen using a checkerboard 
titration experiments. For indirect ELISA format, polyclonal As172 was used at 1: 
32,000 dilution while monoclonals FQ8 and FQ10 were us d at 1 and 0.5 µg.mL-1, 
respectively. In direct ELISA format, As172 was used at 1: 20,000 dilution while FQ8 
and FQ10 were used at of 0.5 and 1 µg.mL-1, respectively. 
Regarding sensitivity, the levels of IC50 and LOD were initially determined for 
all antibodies by direct and indirect format. As shown in Table 1, for As172 and both 















format. The matrix effect studies were initially performed with pig feed extracts spiked 
with enrofloxacin at several concentration levels. Results from preliminary studies 
indicate that the direct ELISA format is less susceptible to the matrix effect than the 
indirect format, as shown in Figure 1. Thus, for As172 and FQ8, a 10 fold dilution of 
the pig feed extract was enough to avoid the matrix effect, i.e. the standards in feed 
extract overlapped with those corresponding to PBS. FQ10 was more affected by the 
feed matrix, and 25 fold dilutions were required to overcome the matrix effect. Besides, 
the results obtained from the direct ELISA formats were more reproducible than the 
indirect ELISA format.  
Based on the previous results, further experiments with other feeds were carried 
out using As172 and FQ8 direct assays. Figure 2 show  standard curves in PBS buffer 
and standard curves in different feed extracts diluted 10 fold for direct competitive 
ELISA with As 172 and FQ8. The results pointed out that As172 was less susceptible to 
the matrix effects than FQ8. Moreover, the cross reactivity studies show that As172 has 
a higher recognition profile and sensitivity for the tested fluoroquinolones than FQ8 
(see Table 2). Hence direct ELISA based on As172 was the optimal choice due to its 
simplicity, sensitivity and tolerance of the matrix effect. 
3.2.  Sample extraction  
The extraction method is highly efficient, with extraction recovery rate above 80% 
for the assayed fluoroquinolones. For the ELISA method it is necessary to dilute the 
extracts with PBS to obtain feed extracts in 10 mM PBS, like the calibration standards. 
Since the addition of PBS to the extracts after centrifugation resulted in salt 















solutions were obtained, ready to be analyzed by the ELISA method. This extraction 
method is simpler and quicker than other reported mthods. 
3.3.  ELISA validation studies 
To study the specificity of the assay, compounds which are structurally related 
to enrofloxacin and compounds from other classes of antibiotics were tested. The IC50, 
LOD (determined as IC90) and the cross-reactivity values in feed for the tested 
fluoroquinolones are shown in Table 2. A significant cross reactivity was obtained with 
the tested compounds, except for flumequine and oxolinic acid (<5%). Hence, the direct 
competitive ELISA could potentially be applied for the determination of most of the 
tested fluoroquinolones. Besides, very low cross reactivity values (<0.1%) shows that 
the antibody doesn’t cross react with tested antibiotics from other classes. This shows 
high group specificity of the developed ELISA method t wards fluoroquinolones. 
Extracts from five different feeds (cow, pig, piglet, hen and chicken) were spiked 
with enrofloxacin at six concentrations levels, from 10-180 µg.L-1. Figure 3 presents the 
correlation between the real concentrations in spiked feeds and the ELISA measured 
concentrations. The slopes and correlation coefficints (R2) of the regression lines 
obtained for the different feeds were between 0.8195- .086 and 0.96-0.99, respectively, 
which indicates good accuracy of the developed assay.   
Feed samples spiked with enrofloxacin at three different concentration levels were 
extracted and analysed to evaluate the recovery of the ELISA method. The recovery 
values were in the range of 75-116 %. In addition, the values measured by ELISA were 
compared with the values obtained by LC-Fl (Table 3). Comparable results were 















The precision of the assay was determined based on inter-assay and intra-assay 
variations in the IC50 and recovery values. The values were expressed as rel tive 
standard deviation of the results obtained from repetitive experiments. Intra-assay 
repeatability based on the variations with-in and between the plates was below 9 % 
(n=3) while the inter-assay reproducibility was below 21 % (n=3). Intra-day and inter-
day precisions in recovery values of pig feed extracts spiked in the range of 10 - 360 
μg.L-1 were below 12 % and 23 %, respectively. The precision in the recoveries of pig 
feeds spiked at 5, 50 and 500 μg.g-1 shows intra-day and inter-day repeatability values 
below 16 % and 25 %, respectively. Moreover, intra-day and inter-day precision varies 
between 15 - 20 % for extracts spiked at CCβ level. 
According to the Commission Decision 2002/657/EC, the determination of CCα is 
not mandatory for screening tests. However, fixing CCα as a discriminating value helps 
in evaluation of the false compliant rate of a screening method for a banned substance. 
Thus, it has been determined as discriminating value for in many screening tests 
(Adrian, et al., 2009; Bovee, Heskamp, Hamers, Hoogenboom, & Nielen, 2005; 
Galarini, et al., 2011; Hagren, Peippo, Tuomola, & Lövgren, 2006; Huet, et al., 2006; 
Jiménez, et al., 2010; Peippo, Lövgren, & Tuomola, 2005; Scortichini, et al., 2009a). In 
this study, CCα and CCβ were determined from repetitive experiments performed on 
blank samples as follows: Accα = Aav-2.33sb ; Accβ = Accα-1.64sb, where Accα, Accβ, Aav 
and sb are absorbance at CCα, absorbance at CCβ, average absorbance of 20 blank feed 
extracts and standard deviation of 20 blank feed extracts, respectively. The 
concentrations are calculated from the absorbance values using enrofloxacin calibration 
curves. CCα was determined to be 10 ng.g
-1 while CCβ was 20 ng.g
-1 in pig feed matrix. 















(Scortichini, Annunziata, Di Girolamo, Buratti, & Galarini, 2009b) indicating a 
powerful sensitivity of the developed method. Once th values of CCα, CCβ were 
determined, evaluation of the false compliant and false non-compliant rates was done by 
analyzing blank feeds. Both α and β error should be less than 5 % for a valid screening 
method as mentioned on Commission Decision 2002/657/EC. In our study, 20 blank 
feeds and 20 spiked feeds (at CCβ level) were analysed to verify the absence of false 
compliant and false non-compliant decisions. Results indicate that the false compliant 
and false non-compliant rates were zero, as shown in Figure 4. 
For robustness study, seven variables (ACN concentration, shaking time, dilution 
factor, competition time, pH of buffer, incubation temperature and delay in instrumental 
reading) were selected for the experimental design based on the Youden approach 
(Youden & Steiner, 1975). The effect of the variables was estimated as the differences 
in results obtained with the variables set at ‘high level’ and ‘low level’ and the effects 
were evaluated with two tailed t-test (Table 4). The level of the tested variables had no 
significant effects (α<0.05) on the results of the ELISA assay, pointing out that the 
method is robust against variations of the selected variables in the assayed ranges. 
Finally, pig feed samples contaminated with enrofloxacin (samples Se1 and Se2), 
danofloxacin (sample Sd), sarafloxacin (sample Ss) were analyzed by LC and the 
proposed ELISA method. Samples were obtained from LAGC, the official laboratory 
for feed analysis in Catalonia (Spain), and from loca  feed producers. Concentrations of 
danofloxacin and sarafloxacin obtained by the ELISA method were expressed as 
equivalents of enrofloxacin considering their cross reactivities (Table 5). Comparable 
results were obtained from both methods indicating that the proposed method can 
















The ELISA proposed method, which combines a very simple sample treatment with a 
direct ELISA based on a polyclonal antiserum As172, can be applied for a throughput 
screening of fluoroquinolones residues in feed samples and it is well suited for 
screening large number of samples. Unlike other ELISA assays, no treatment of the 
sample extract other than dilution was involved, even for complex feeds samples. Thus, 
only 10-fold dilution of the final feed extract is required to avoid the matrix effect when 
using polyclonal antiserum As172 compared to monoclonal ones. Moreover, the 
relevant cross-reactivity of the assay towards fluoroquinoles indicates higher 
recognition profile and sensitivity of the polyclonal antiserum As172 in the direct 
format. This enables accurate and broad range detection for this family of compounds. 
A detection capability of 20 ng.g-1 for enrofloxacin indicates that the method is very 
sensitive. All these, in addition to the robustness of the assay, makes this ELISA method 
very suitable for effective control of cross contamination during feed production or to 
detect unauthorized use of fluoriquinolones in bad farming practices. 
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Figure 1. Standard curves for enrofloxacin in PBS and in feed xtracts diluted at three 
different levels (5, 10 and 25 fold). The assay wasdone following direct (a, b and c) and 
indirect (d, e and f) ELISA formats with three different antibodies. M/5, M/10 and M/25 
represent 5, 10 and 25 fold dilutions of the feed extracts. A/10 represents 10 fold 
dilution of the extracting solution. The pH of the blank feed extracts was adjusted to 7.5 
after dilution. 
Figure 2. Standard curve for enrofloxacin in PBS and in extracts from three different 
blank feeds (pig, cow and piglet) diluted 10 fold. The assay was done following direct 
ELISA format with antibodies As172 (a) and FQ8 (b). The pH of the blank feed extracts 
was adjusted to 7.5 after dilution. 
Figure 3. Accuracy studies with feed extracts spiked at six different concentrations (11, 
22, 45, 90, 135, 180 µg.L-1) with enrofloxacin. Each data represents the mean value of 
three independent experiments with 95 % confidence limit.
Figure 4. Verification of the absence of false compliant and false non-compliant. CCα 
and CCβ were determined from the variations in the absorbance of 20 blank feeds. 
Determinations were made using standard curves obtained from quadruplicate data; 

















Table 1. IC50 and LOD values for enrofloxacin in phosphate buffer solution with direct 
and indirect ELISA format employing polyclonal antiserum (As172) and monoclonal 
antibodies (FQ8 or FQ10). 
         





































-1) LOD (ng.mL-1)*  
Direct ELISA Indirect ELISA Direct ELISA Indirect ELISA 
As172 10.5 78.2 0.5 8.4 
FQ8 5.5 94.6 0.6 39.2 




























*LOD values were estimated as IC90










% Cross Reactivity 
Enrofloxacin 15.2 1.3 100 16.3 0.8 100 
Ciprofloxacin 7.181 0.5 211.1 10.3 0.6 157.9 
Sarafloxacin 4.259 0.04 355.9 42 8.7 38.7 
Difloxacin 3.684 0.03 411.4 41 4.6 39.7 
Ofloxacin 20.9 1 72.6 - - - 
Danofloxacin 35.6 0.4 42.6 33.9 3 48 
Norfloxacin 7.2 0.3 210.1 32.2 2.8 50.5 
Marbofloxacin 33.4 2.3 45.4 21.7 2.3 74.8 
Oxolinic Acid 291.3 14.9 5.2 - - - 














Table 3. Comparison of the determinations for different spike levels of pig feed by 
ELISA and LC methods; ELISA assay was performed in irect format using polyclonal 
antiserum As172. 
          *Calculated from three determinations in three different days 



















% RSD* Measured 
Value, µg.g-1 
% RSD** 
5 3.9 15 4.2 2 
50 58 23 44 5 













Table 4. Minor variations in the selected variables for robustness study for the optimal direct ELISA format using polyclonal antiserum As172, 






















*The recovery values were obtained by analyzing a 5 µg.g-1 of pig feed with the designed experiments. 






Selected variables Unit 
Optimal 
value 
Higher values Low values 




ACN Concentration % 50 % 45 55 12.8 1.18 
Shaking time min 1.5 1.25 1.75 18.9 1.74 
Dilution factor - 1:10 1:8 1:12 10.4 0.96 
Compition time min 30 25 35 18.3 1.69 
pH of buffer - 7.5 7.3 7.7 6.4 0.59 
Incubation 
temperature 
0C 25 21 28 17.8 1.64 













Table 5. Comparison of the determinations of contaminated pig feeds by ELISA and 
LC methods; ELISA measurements were done following a direct format using 
polyclonal antiserum As172. 
       *Calculated from six replicate determinations 
 
 
Sample LC ELISA 
Measured Value, ng.g-1 % RSD* Measured Value, ng.g-1 % RSD* 
Se1 0.2 7.1 0.4 15 
Se2 4.6 8.2 5.0 12 
Sd 14 3.0 12 9 
























































































































Feeds Spiked at CC
Blank feeds
CC = 10 ng.g
-1
































• A quick screenig method for fluoroquinolone in feeds based on ELISA is validated.  
• Matrix effect is avoided by only 10 fold dilution of the final feed extract. 
• The achieved CCβ of 20 ng.g-1 for enrofloxacin indicates sufficient sensitivity. 
• Good correlation of the method with LC-Fl indicates promising reliability. 
 
